What Happens When You Stop ‘Skinny Jabs’? | BBC News

Key Concepts

• GLP-1s (Glucagon-Like Peptide-1 Receptor Agonists): Medications (Semaglutide - Wegovy, Tepatide - Mounjaro, Liraglutide - Saxenda) used for weight loss by mimicking a natural hormone, regulating blood sugar, appetite, and slowing digestion.
• Food Noise: Persistent, repetitive, and intrusive thoughts about food, often reduced by GLP-1s but potentially returning upon cessation.
• Set Point Theory: The idea that the body actively resists changes in weight and attempts to return to a biologically predetermined weight range.
• BMI (Body Mass Index): A standard measure of body fat based on height and weight, though acknowledged to have limitations.
• Weight Regain: The common experience of regaining lost weight after discontinuing GLP-1 medications, often linked to insufficient lifestyle changes.
• Social Currency & Body Image: The increasing societal pressure, amplified by social media, to achieve a specific body type, impacting both men and women.

The Rise of Weight Loss Injections: A Detailed Overview

Introduction: The Shifting Landscape of Weight Loss

The video explores the burgeoning popularity of weight loss injections, specifically GLP-1s, and their impact on individuals and society. Historically, weight loss has been approached through dieting, with fluctuating trends (“keep fit craze hitting Kensington,” the “rack” as a torture device for stretching). However, GLP-1s represent a significant shift, offering a pharmaceutical approach that many are experiencing as a “miracle cure.” As of 2025, an estimated 1.5 million people in the UK (roughly 1 in 46, or over 2% of the population) are utilizing these injections.

The Prevalence of Obesity and Driving Factors

The surge in GLP-1 use is directly linked to rising obesity rates. In England, 28% of the population is obese and 36% are overweight, totaling nearly 64% falling into these categories. Similar trends are observed across the UK. This is driven by health concerns (Type 2 Diabetes, high blood pressure, increased cancer risk – the second biggest risk factor), body image issues, and mental health impacts. The video highlights that body weight increasingly impacts “social currency,” with societal pressures, particularly amplified by social media and reality TV, promoting a specific body type as a pathway to fame and success. This pressure is no longer solely focused on women, with more men facing scrutiny.

GLP-1 Medications: Types and Mechanisms

Three primary GLP-1 medications are currently available: Semaglutide (Wegovy), Tepatide (Mounjaro), and Liraglutide (Saxenda). These drugs require a prescription from a healthcare professional and can be accessed through the NHS or private clinics/pharmacies. GLP-1s function by mimicking a natural hormone released after eating, regulating blood sugar and appetite. Specifically, they stimulate insulin release, suppress glucagon secretion (preventing blood sugar spikes), and slow down digestion, leading to increased feelings of fullness. The goal is to reduce cravings and support a calorie deficit.

Financial Burden and Accessibility

While offering potential benefits, GLP-1s come with a significant financial cost. Private buyers can spend substantial amounts – one individual spent £2,000 on injections, with prices increasing. The video features a case study of patients selling personal belongings ("kitchen items and furniture") to afford the medication. In September 2025, Mounjaro experienced a price hike, aligning it with costs in other countries. This financial strain raises concerns about equitable access.

Personal Experiences: Benefits and Challenges

The video features several personal accounts:

• Emma (GP & Patient): Struggled with weight since adolescence, repeatedly failing with diets. Reached a point of bordering morbid obesity and felt panicked. Used GLP-1s to “speed up” weight loss and address feelings of being an “impostor” in the fitness industry. Also used them after a hysterectomy and cancer treatments that caused weight gain, fearing surgery complications due to her weight.
• Individual 1: Lost four stone (approximately 56 pounds) on Mounjaro, experiencing a positive impact on career perception.
• Individual 2: Lost three stone and eight pounds (approximately 48 pounds) over 22 weeks, initially concealing use from her husband.
• Individual 3: Experienced significant weight loss (nearly 60 pounds) but faced challenges with cost and eventual cessation.

These accounts highlight the potential for significant weight loss and improved self-perception, but also the emotional and financial burdens associated with these medications.

Coming Off the Jab: The Re-Emergence of Food Noise and Weight Regain

A critical focus of the video is the experience of discontinuing GLP-1s. It’s not a simple process; gradual dose reduction is recommended to minimize the abrupt return of appetite. The video emphasizes the importance of an “exit strategy” developed before starting the medication, including setting realistic goals and planning for lifestyle changes.

A key challenge is the return of “food noise” – persistent, intrusive thoughts about food. Individuals describe it as a “tsunami” of cravings, a feeling of being constantly hungry despite adequate caloric intake. One individual described it as a switch flipping back on after 19 months of suppression.

Weight regain is common, with estimates suggesting 60-80% of lost weight returning within one to three years if lifestyle changes aren’t maintained. The body’s “set point theory” is invoked, explaining the body’s natural tendency to regain lost weight. Individuals reported regaining weight quickly after stopping, with one person gaining a stone (approximately 14 pounds) within a month.

Side Effects and Long-Term Unknowns

GLP-1s can cause side effects like stomach pain, headaches, and hair loss. Rare but serious risks include pancreatitis and potential impacts on contraceptive effectiveness. Due to the relative novelty of these medications, the long-term effects remain largely unknown.

The Psychological Component: Addiction and Obsession

The video explores the psychological aspects of GLP-1 use. Individuals can develop an “addiction” to the feeling of control and the positive social feedback associated with weight loss. One individual expressed a fear of regaining weight and a willingness to remain on the medication indefinitely. The praise received for weight loss, even if due to medication, can be addictive, creating a complex dynamic.

The Future of Obesity Treatment and Societal Implications

The video concludes by emphasizing the need for a holistic approach to obesity treatment. While GLP-1s can be a valuable tool, they are not a “miracle cure.” Lifestyle changes – diet, exercise, and behavioral therapy – are crucial for long-term success. The video also calls for a shift in societal attitudes towards obesity, moving away from shaming and towards supportive interventions. There is significant investment in obesity medicine, including the development of oral GLP-1s, but a focus on lifestyle factors remains paramount. The increasing accessibility of weight loss medications raises questions about how society views and treats bodies of different sizes, potentially leading to increased pressure to conform to a specific ideal.

Notable Quotes:

• “For me, it's more threatening to go back to what I used to feel like than to say, 'What happens if you're on this drug forever?'” – Patient expressing fear of weight regain.
• “It’s like just genuinely being hungry. And even though you know you've had enough to eat, your brain's not telling you that. It's like it's a mind trick.” – Description of food noise.
• “Body likes putting on weight. It's great for survival. Fat is a fantastic energy store.” – Explanation of set point theory.

Conclusion:

GLP-1 medications represent a significant advancement in the treatment of obesity, offering substantial weight loss potential for many. However, they are not without their challenges – financial burden, potential side effects, the complexities of cessation, and the psychological impact. Long-term success requires a comprehensive approach that combines medication with sustainable lifestyle changes and a shift in societal attitudes towards weight and body image. Further research is needed to fully understand the long-term effects of these medications and to develop effective strategies for managing weight regain and supporting individuals throughout their weight loss journey.